22 results
424B3
CHRO
Chromocell Therapeutics Corp.
15 May 24
Prospectus supplement
4:21pm
General and administrative expenses
Research and development
Professional fees
Total operating expenses
NET LOSS FROM OPERATIONS
OTHER (EXPENSE) INCOME … limits.
Research and Development
We incur research and development costs during the process of researching and developing our technologies and future
424B3
CHRO
Chromocell Therapeutics Corp.
15 May 24
Prospectus supplement
4:15pm
General and administrative expenses
Research and development
Professional fees
Total operating expenses
NET LOSS FROM OPERATIONS
OTHER (EXPENSE) INCOME … limits.
Research and Development
We incur research and development costs during the process of researching and developing our technologies and future
10-Q
2024 Q1
CHRO
Chromocell Therapeutics Corp.
15 May 24
Quarterly report
4:06pm
EXPENSES
General and administrative expenses
Research and development
Professional fees
Total operating expenses
NET LOSS FROM OPERATIONS
OTHER (EXPENSE … cash equivalents.
As of March 31, 2024, the Company had deposits in excess of federally insured limits.
Research and Development
We incur research
10-Q
2024 Q1
EX-10.3
CHRO
Chromocell Therapeutics Corp.
15 May 24
Quarterly report
4:06pm
, technologies, therapies or services in any way related to the therapeutic mechanisms of action that are being evaluated in the Company’s active research … and development efforts at that time. It is agreed that ownership of no more than one percent (1%) of the outstanding voting stock of a publicly traded
424B3
CHRO
Chromocell Therapeutics Corp.
16 Apr 24
Prospectus supplement
5:49pm
and local levels, as well as outside the United States, extensively regulate, among other things, the research, development, testing, manufacture … our ability to raise capital, maintain our research and development efforts, expand our business or continue our operations. A decline in the value
424B3
yxkaogqnddq
16 Apr 24
Prospectus supplement
5:45pm
10-K
roo6s3n9ix76u
16 Apr 24
Annual report
4:48pm
424B4
vctuxhyl8pnr6 yryv
20 Feb 24
Prospectus supplement with pricing info
5:30pm
424B4
5h9 9tabasyuv1
20 Feb 24
Prospectus supplement with pricing info
5:28pm